SpyBiotech Company
SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.
Technology:
Atrificial Vectors and Immune Cells
Industry:
Atrificial Vectors and Immune Cells
Headquarters:
Oxford, Oxfordshire, United Kingdom
Founded Date:
2017-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
5
Total Funding:
316567683
Estimated Revenue:
Less than $1M
Last Funding Date:
2021-02-10
Last Funding Type:
Series A
Register and Claim Ownership